Amgen quarterly profit rises 15% as Horizon deal boosts results

Deena Beasley
2 min read
0
In this article:

By Deena Beasley

Feb 6 (Reuters) - Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.

Revenue for the quarter totaled $8.2 billion, edging ahead of analysts' estimates of $8.1 billion, according to LSEG data.

Excluding Horizon's medications, Amgen said year-over-year product sales grew 5% as volume growth of 9% was partially offset by lower net selling prices.

Adjusted earnings per share rose to $4.71 from $4.09 a year earlier, beating analyst estimates of $4.61.

Quarterly net profit fell 53% to $1.42 per share due to expenses related to the Horizon deal.

For full-year 2024, the company said it expects adjusted earnings per share of $18.90 to $20.30 on revenue of $32.4 billion to $33.8 billion. Analysts are estimating 2024 earnings of $20.02 per share and revenue of $32.7 billion.

The outlook reflects the addition of Horizon as well as more volume driven growth in worldwide sales of Amgen's drugs, Chief Financial Officer Peter Griffith told Reuters.

Quarterly product sales were led by a 12% jump to $1.1 billion for the osteoporosis drug Prolia. Sales of rheumatoid arthritis drug Enbrel fell 8% to just over $1 billion.

Amgen's $27.8 billion acquisition of Horizon was finalized after the U.S. Federal Trade Commission removed its opposition in exchange for Amgen agreeing not to use anticompetitive tactics.

For the period between the deal's Oct. 6 close and the end of last year, Amgen said sales of Tepezza, Horizon's thyroid eye disease drug, totaled $448 million, while sales of gout drug Krystexxa were $272 million.

Amgen said it remains on track to report the first human trial data for its experimental oral obesity drug AMG786 in the first half of this year, and to announce results from a mid-stage trial of its lead injectable weight loss candidate, MariTide, late this year.

"We anticipate more than a dozen significant pipeline milestones in 2024," Amgen CEO Robert Bradway said in statement.

Amgen said it plans to buy back no more than $500 million its shares this year. "We are focused on our deleveraging goals," Griffith said.

(Reporting By Deena Beasley Editing by Bill Berkrot)

Advertisement

Recommended Stories

  • Mortgage rates today, April 27, 2024: 30-year and 15-year rates inch up

    These are today's mortgage rates. If you can comfortably afford a mortgage with today's rates, you may want to start looking at homes. Lock in your rate today.

  • Aon profit misses estimates on weakness in US retail brokerage business

    While the company's retail brokerage revenue grew on the back of solid growth in EMEA, Asia and the Pacific, U.S. results faced pressure from lower net new business and the ongoing impacts from external capital markets activity, TD Cowen analysts said in a note. Still, interest income rose nearly six times to $28 million in the first quarter ended March, primarily due to interest earned on $5 billion investment of debt proceeds used to fund the purchase of NFP. Last year, Aon agreed to buy privately held NFP in a deal valued at about $13.4 billion to tap the fast-growing middle-market segment of insurance brokerage, wealth management and retirement plan advisory.

  • What is mortgage principal, and how do I pay it off?

    Mortgage principal is the amount you owe on the money you borrowed from the lender, not including interest. Learn how mortgage principal affects your payments.

  • Snap Signals Ad Revamp Is Finding an Audience; Shares Surge

    (Bloomberg) -- Snap Inc. offered positive signs that its efforts to revamp its digital advertising business are gaining popularity with marketers — boosting revenue and providing stronger competition with powerhouses Google and Meta Platforms Inc. The shares surged the most in more than two years on Friday morning.Most Read from BloombergBHP’s $39 Billion Copper Play Was Years in the MakingApple Intensifies Talks With OpenAI for iPhone Generative AI FeaturesAI Boom’s Secret Winners? The Companie

  • Some Americans filed free with IRS Direct File pilot in 2024, but not everyone's a fan

    IRS says more than 140,000 Americans filed their taxes free using its Direct File pilot but industry critics say the program's unnecessary and costly.

  • Oregon's Sports Bra, a pub for women's sports fans, plans national expansion as interest booms

    On a recent weeknight at this bar in northeast Portland, fans downed pints and burgers as college women's lacrosse and beach volleyball matches played on big-screen TVs. Memorabilia autographed by female athletes covered the walls, with a painting of U.S. soccer legend Abby Wambach mounted above the chalkboard beer menu. The Sports Bra is a pub where women's sports are celebrated — and the only thing on TV.

  • Surging auto insurance rates squeeze drivers, fuel inflation

    Relentlessly rising auto insurance rates are squeezing car owners and stoking inflation. Auto insurance rates rose 2.6% in March and are up 22% from a year ago. Premium costs have been marching steadily higher since 2022, even as inflation at the consumer level steadily cooled from its 9.1% peak in the middle of that year.

  • Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead

    There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.

  • Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves

    The $50 million purchase could turn into Nvidia's biggest investment.

  • Trump to set interest rates himself under secret presidential plan

    Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.